FAPI promising diagnostic performance paved the way also to tailored radioligand therapy (RLT) [73], delivering the therapeutic isotope to the sites expressing FAP, thus enhancing new frontiers for lung cancer therapy. This evidence concerns the gene FAP and lung carcinoma.